Revolutionizing Pharma: The Strategic Guide to AI Deployment
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Stage III Renal Cell Cancer AJCC v8
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB00062
Albumin human
1
Recruiting
1
DB11595
Atezolizumab
1
Recruiting
1
DB08875
Cabozantinib
1
Active Not Recruiting
3
DB08875
Cabozantinib
1
Recruiting
1
DB01373
Calcium
1
Active Not Recruiting
1
DB04690
Camptothecin
1
Active Not Recruiting
1
DB01101
Capecitabine
1
Active Not Recruiting
1
DB00958
Carboplatin
1
Active Not Recruiting
1
DB00531
Cyclophosphamide
1
Active Not Recruiting
1
DB00531
Cyclophosphamide
1
Recruiting
1
DB00694
Daunorubicin
1
Active Not Recruiting
1
DB00997
Doxorubicin
1
Active Not Recruiting
1
DB08871
Eribulin
1
Active Not Recruiting
1
DB01175
Escitalopram
1
Active Not Recruiting
1
DB00544
Fluorouracil
1
Active Not Recruiting
1
DB06186
Ipilimumab
1
Active Not Recruiting
3
DB06186
Ipilimumab
1
Recruiting
1
DB00762
Irinotecan
1
Active Not Recruiting
1
DB00650
Leucovorin
1
Active Not Recruiting
1
DB11596
Levoleucovorin
1
Active Not Recruiting
1
DB09035
Nivolumab
1
Active Not Recruiting
5
DB09035
Nivolumab
1
Recruiting
1
DB09074
Olaparib
1
Active Not Recruiting
1
DB00526
Oxaliplatin
1
Active Not Recruiting
1
DB01229
Paclitaxel
1
Active Not Recruiting
1
DB01229
Paclitaxel
1
Recruiting
1
DB09037
Pembrolizumab
1
Active Not Recruiting
1
DB09037
Pembrolizumab
1
Recruiting
1
DB00642
Pemetrexed
1
Active Not Recruiting
1
DB00020
Sargramostim
1
Recruiting
1
DB11942
Selinexor
1
Active Not Recruiting
1
DB01030
Topotecan
1
Active Not Recruiting
1
DB11595
Atezolizumab
1 / 2
Recruiting
1
DB11945
Avelumab
1 / 2
Recruiting
1
DB11714
Durvalumab
1 / 2
Recruiting
1
DB09035
Nivolumab
1 / 2
Recruiting
1
DB09037
Pembrolizumab
1 / 2
Recruiting
1
DB05992
Plinabulin
1 / 2
Recruiting
1
DB11740
Adavosertib
2
Active Not Recruiting
1
DB00126
Ascorbic acid
2
Terminated
1
DB11595
Atezolizumab
2
Recruiting
1
DB11945
Avelumab
2
Recruiting
1
DB06626
Axitinib
2
Active Not Recruiting
1
DB06626
Axitinib
2
Recruiting
2
DB00112
Bevacizumab
2
Recruiting
1
DB08875
Cabozantinib
2
Active Not Recruiting
1
DB08875
Cabozantinib
2
Recruiting
3
DB00694
Daunorubicin
2
Active Not Recruiting
1
DB00997
Doxorubicin
2
Active Not Recruiting
1
DB00530
Erlotinib
2
Recruiting
1
DB01590
Everolimus
2
Recruiting
1
DB09398
Fluoride ion F-18
2
Recruiting
1
DB00441
Gemcitabine
2
Active Not Recruiting
1
DB06186
Ipilimumab
2
Active Not Recruiting
1
DB06186
Ipilimumab
2
Recruiting
2
DB09570
Ixazomib
2
Active Not Recruiting
1
DB09078
Lenvatinib
2
Recruiting
3
DB09035
Nivolumab
2
Active Not Recruiting
2
DB09035
Nivolumab
2
Recruiting
3
DB06589
Pazopanib
2
Terminated
1
DB09037
Pembrolizumab
2
Recruiting
3
DB08875
Cabozantinib
3
Recruiting
1
DB06186
Ipilimumab
3
Recruiting
1
DB09035
Nivolumab
3
Recruiting
1